Neuphoria Therapeutics Inc. (NASDAQ:NEUP) stock soared over 20% following the announcement that the company will receive a ...
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
Merck reported adjusted EPS of $1.72 ... up from a prior $129. Across the commercial portfolio, the analyst remains bullish on Winrevair's potential. Analyst Shibutani writes that the company ...